
Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter
Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter

Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter
Knight Therapeutics Announces Relaunch of MYFEMBREE(TM) in Canada
Opensesame details QT with Vector Science
MedX Health completes $527,500 closing of placement
MedX announces Initial Closing and Proposed Extension of Non-Brokered Private Placement
Ventripoint to extend, increase debenture financing
Ventripoint Announces Extension and Up Size of Non-Brokered Convertible Debenture Unit Private Placement
Myndtec closes $104,421 fifth tranche of placement
Pharmacorp Rx closes acquisition of three pharmacies
MyndTec Inc. Completes Fifth Tranche of Non-Brokered Private Placement
PharmaCorp Closes Acquisitions of Three Pharmacies Across Canada
Pharmather clarifies sale of one generic ketamine asset
Quantum Biopharma receives toxicity study reports
Premier Health's Quebec units ineligible under act
Zyus adds two clinical sites to phase 2a Utopia-1 trial